Dataset Information

Adsorption of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) from water using leaf biomass (Vitis vinifera) in a fixed-bed column study.

ABSTRACT:

Introduction

Adsorption of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) onto modified activated carbons (AC-H₃PO₄) produced from leaf biomass of Vitis vinifera leaf litter in a fixed bed column experiment was investigated in this study.

Methods

The column bed was packed with the produced activated carbons in a uniform particle size of ? 64 ?m. Experimental parameters including the initial concentration of the solution, column bed height, the mass of adsorbent and flow rate were optimized to establish the best adsorption efficiency parameters for the system. Breakthrough and saturated time were estimated from the column fixed bed experimental data and analysed using the Adam-Bohart, Thomas model, and Yoon-Nelson models.

Results

Maximum sorption capacities of produced activated carbon ACH₃PO₄ based on Thomas model were 159.61 and 208.64 mg/g for PFOA and PFOS, respectively. The results indicated the breakthrough and saturated time of the system increased concurrently with the increase in bed height and initial concentrations, while an increase in flow rate enhanced fractional bed utilization (FBU) efficiency of the column. Thomas and Yoon-Nelson model best describe the prediction of breakthrough data and sorption behaviour of PFOA and PFOS indicating suitability of AC-H₃PO₄ column design.

Conclusion

Findings suggest that agro based adsorbent is a good alternative to non-ago based adsorbent. The surface characteristics of the phosphoric acid modified activated carbons AC-H₃PO₄ affirmed the removal of PFOA and PFOS from the contaminated water.

SUBMITTER: Fagbayigbo BO

PROVIDER: S-EPMC7203292 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Adsorption of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) from water using leaf biomass (<i>Vitis vinifera</i>) in a fixed-bed column study.

Fagbayigbo B O BO Opeolu B O BO Fatoki O S OS

Journal of environmental health science & engineering 20200220 1

<h4>Introduction</h4>Adsorption of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) onto modified activated carbons (AC-H<sub>3</sub>PO<sub>4</sub>) produced from leaf biomass of <i>Vitis vinifera</i> leaf litter in a fixed bed column experiment was investigated in this study.<h4>Methods</h4>The column bed was packed with the produced activated carbons in a uniform particle size of ˃ 64 μm. Experimental parameters including the initial concentration of the solution, column bed ...[more]

PMID: 32399234

Similar Datasets

Project description:Perfluorooctane sulfonate (PFOS) has been widely utilized in numerous industries. Due to long environmental and biological half-lives, PFOS is a major public health concern. Although the literature suggests that PFOS may induce neurotoxicity, neurotoxic mechanisms, and neuropathology are poorly understood. Thus, the primary goal of this study was to determine if PFOS is selectively neurotoxic and potentially relevant to specific neurological diseases. Nematodes (Caenorhabditis elegans) were exposed to PFOS or related per- and polyfluoroalkyl substances (PFAS) for 72 h and tested for evidence of neuropathology through examination of cholinergic, dopaminergic, gamma-amino butyric acid (GABA)ergic, and serotoninergic neuronal morphologies. Dopaminergic and cholinergic functional analyses were assessed through 1-nonanol and Aldicarb assay. Mechanistic studies assessed total reactive oxygen species, superoxide ions, and mitochondrial content. Finally, therapeutic approaches were utilized to further examine pathogenic mechanisms. Dopaminergic neuropathology occurred at lower exposure levels (25 ppm, approximately 50 µM) than required to produce neuropathology in GABAergic, serotonergic, and cholinergic neurons (100 ppm, approximately 200 µM). Further, PFOS exposure led to dopamine-dependent functional deficits, without altering acetylcholine-dependent paralysis. Mitochondrial content was affected by PFOS at far lower exposure level than required to induce pathology (≥1 ppm, approximately 2 µM). Perfluorooctane sulfonate exposure also enhanced oxidative stress. Further, mutation in mitochondrial superoxide dismutase rendered animals more vulnerable. Neuroprotective approaches such as antioxidants, PFAS-protein dissociation, and targeted (mitochondrial) radical and electron scavenging were neuroprotective, suggesting specific mechanisms of action. In general, other tested PFAS were less neurotoxic. The primary impact is to prompt research into potential adverse outcomes related to PFAS-induced dopaminergic neurotoxicity in humans.

Project description:Globally, biomonitoring data demonstrate virtually all humans carry residues of multiple per- and polyfluoroalkyl substances (PFAS). Despite pervasive co-exposure, limited mixtures-based in vivo PFAS toxicity research has been conducted. Perfluorooctanoic acid (PFOA) and perfluorooctane sulfonic acid (PFOS) are commonly detected PFAS in human and environmental samples and both produce adverse effects in laboratory animal studies, including maternal and offspring effects when orally administered during pregnancy and lactation. To evaluate the effects of combined exposure to PFOA and PFOS, we orally exposed pregnant Sprague-Dawley rats from gestation day 8 (GD8) to postnatal day 2 (PND2) to PFOA (10-250 mg/kg/d) or PFOS (0.1-5 mg/kg/d) individually to characterize effects and dose response curve parameters, followed by a variable-ratio mixture experiment with a constant dose of PFOS (2 mg/kg/d) mixed with increasing doses of PFOA (3-80 mg/kg/d). The mixture study design was intended to: 1) shift the PFOA dose response curves for endpoints shared with PFOS, 2) allow comparison of dose addition (DA) and response addition (RA) model predictions, 3) conduct relative potency factor (RPF) analysis for multiple endpoints, and 4) avoid overt maternal toxicity. Maternal serum and liver concentrations of PFOA and PFOS were consistent between the individual chemical and mixture experiments. Combined exposure with PFOS significantly shifted the PFOA dose response curves towards effects at lower doses compared to PFOA-only exposure for multiple endpoints and these effects were well predicted by dose addition. For endpoints amenable to mixture model analyses, DA produced equivalent or better estimates of observed data than RA. All endpoints evaluated were accurately predicted by RPF and DA approaches except for maternal gestational weight gain, which produced less-than-additive results in the mixture. Data support the hypothesis of cumulative effects on shared endpoints from PFOA and PFOS co-exposure and dose additive approaches for predictive estimates of mixture effects.